The packaging image may vary depending on the country in which it is marketed.

Logotipo Laboratorios Ovejero
Manufacturer
Laboratorios Ovejero, S.A.
Medicinal product subject to veterinary prescription

MASTIVAC

Inactivated vaccine against bovine mastitis, in an injectable suspension
Target species
Cattle (heifers and cows) icon
Cattle (heifers and cows)
Composition per dose (5 ml)
Each dose (5 ml) contains:

Active substances:
Inactivated S. agalactiae, strain LO1 ≥1 P.R.*
Inactivated S. dysgalactiae , strain ATCC 43078 ≥1 P.R.*
Inactivated S. uberis, strain LO1 ≥1 P.R.*
Inactivated S. pyogenes, strain LO1 ≥1 P.R.*
Inactivated S. aureus, strain LO1 ≥1 P.R.*
Inactivated A. pyogenes, strain ATCC 9730 ≥1 P.R.*
Inactivated E. coli, strain Bov-10 ≥1 P.R.*
Inactivated E. coli, strain Bov-14 ≥1 P.R.*
Inactivated E. coli, strain Bov-15 ≥1 P.R.*
Inactivated E. coli, strain Suis-21 ≥1 P.R.*
Inactivated E. coli, strain J5 ATCC 43745 ≥1 P.R.*

*Relative Potency (ELISA in rabbit serum, compared to a reference vaccine)


Adjuvant:
Aluminium hydroxide (Al3+) 8,5 mg
Indications
For active immunisation against clinical and/or subclinical mastitis in cattle caused by the following microorganisms: Streptococcus agalactiae, Streptococcus dysgalactiae, Streptococcus uberis, Streptococcus pyogenes, Staphylococcus aureus, Arcanobacterium pyogenes and Escherichia coli.

Reduces the clinical signs of clinical mastitis caused by Streptococcus dysgalactiae, Streptococcus pyogenes, Arcanobacterium pyogenes and Escherichia coli.

Reduces the somatic cell count in subclinical mastitis caused by Streptococcus agalactiae,Streptococcus uberis and Staphylococcus aureus.

  • Onset of immunity: 8–10 days after the application of the second dose.
  • Duration of immunity: At least 6 months.
Route of administration
Subcutaneous.
Dosage
Dose: 5 ml.
Vaccination schedule:
  • Primary vaccination:
    • 2 doses. 15 days apart.
      • Heifers: 2 months before the first calving.
      • Cows: At any time, regardless of the physiological state of the animal.
  • Revaccination:
    • 1 dose. Every 6 months.
Withdrawal period
Zero days.

La imagen puede variar dependiendo del país en el que se comercialice.

Laboratorio fabricante
Laboratorios Ovejero, S.A.
Medicamento sujeto a prescripción veterinaria

MASTIVAC

Inactivated vaccine against bovine mastitis, in an injectable suspension
Composición por dosis (5 ml)
Each dose (5 ml) contains:

Active substances:
Inactivated S. agalactiae, strain LO1 ≥1 P.R.*
Inactivated S. dysgalactiae , strain ATCC 43078 ≥1 P.R.*
Inactivated S. uberis, strain LO1 ≥1 P.R.*
Inactivated S. pyogenes, strain LO1 ≥1 P.R.*
Inactivated S. aureus, strain LO1 ≥1 P.R.*
Inactivated A. pyogenes, strain ATCC 9730 ≥1 P.R.*
Inactivated E. coli, strain Bov-10 ≥1 P.R.*
Inactivated E. coli, strain Bov-14 ≥1 P.R.*
Inactivated E. coli, strain Bov-15 ≥1 P.R.*
Inactivated E. coli, strain Suis-21 ≥1 P.R.*
Inactivated E. coli, strain J5 ATCC 43745 ≥1 P.R.*

*Relative Potency (ELISA in rabbit serum, compared to a reference vaccine)


Adjuvant:
Aluminium hydroxide (Al3+) 8,5 mg
Indicaciones
For active immunisation against clinical and/or subclinical mastitis in cattle caused by the following microorganisms: Streptococcus agalactiae, Streptococcus dysgalactiae, Streptococcus uberis, Streptococcus pyogenes, Staphylococcus aureus, Arcanobacterium pyogenes and Escherichia coli.

Reduces the clinical signs of clinical mastitis caused by Streptococcus dysgalactiae, Streptococcus pyogenes, Arcanobacterium pyogenes and Escherichia coli.

Reduces the somatic cell count in subclinical mastitis caused by Streptococcus agalactiae,Streptococcus uberis and Staphylococcus aureus.

  • Onset of immunity: 8–10 days after the application of the second dose.
  • Duration of immunity: At least 6 months.
Vía de administración
Subcutaneous.
Posología
Dose: 5 ml.
Pauta de vacunación
  • Primary vaccination:
    • 2 doses. 15 days apart.
      • Heifers: 2 months before the first calving.
      • Cows: At any time, regardless of the physiological state of the animal.
  • Revaccination:
    • 1 dose. Every 6 months.
Tiempo de espera
Zero days.
Scroll to Top